- Termination of Registration of a Class of Security under Section 12(g) (15-12G)
June 01 2010 - 4:21PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION
12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE
REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number
000-51314
Winston Pharmaceuticals, Inc.
(Exact name of registrant as specified in its charter)
100 North Fairway Drive, Suite 134
Vernon Hills, IL, 60061
Tel: (847) 862-8200
(Address, including zip code, and telephone number, including area code, of registrants principal
executive offices)
Common Stock, $0.001 par value per share
(Title of each class of securities covered by this Form)
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or
15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to
terminate or suspend the duty to file reports:
|
|
|
Rule 12g-4(a)(1)
|
|
o
|
Rule 12g-4(a)(2)
|
|
þ
|
Rule 12h-3(b)(1)(i)
|
|
o
|
Rule 12h-3(b)(1)(ii)
|
|
þ
|
Rule 15d-6
|
|
o
|
Approximate number of holders of record as of the certification or notice date:
450
Pursuant to the requirements of the Securities Exchange Act of 1934, Winston Pharmaceuticals,
Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly
authorized person.
|
|
|
|
|
|
|
|
Date:
June 1, 2010
|
By
|
/s/ Joel E. Bernstein
|
|
|
|
Joel E. Bernstein, M.D.
|
|
|
|
President and Chief Executive Officer
|
|
|
Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and
Regulations under the Securities Exchange Act of 1934. The registrant shall file with the
Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an
officer of the registrant, by counsel or by any other duly authorized person. The name and title of
the person signing the form shall be typed or printed under the signature.
Winston Pharmaceuticals (CE) (USOTC:WPHM)
Historical Stock Chart
From Oct 2024 to Nov 2024
Winston Pharmaceuticals (CE) (USOTC:WPHM)
Historical Stock Chart
From Nov 2023 to Nov 2024